ArticleIndian journal of endocrinology and metabolism

Therapeutic Experience of Saxagliptin as First Add-on after Metformin in Indian Type 2 Diabetes Patients: A Non-interventional, Prospective, Observational Study (ONTARGET-INDIA).

Sanjay Kalra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.